Global Device Distribution and Manufacturing Services
Recent news:
August 16, 2010:
MDS is proud to announce a very successful launch of the newly FDA released patient monitor, IRIS. MDS also launched a very useful wireless tablet PC for multiple patient vital signs tracking called i-Care. The i-Care tablet PC works in conjunction with a single or multiple IRIS units and includes a camera for wound care analysis, bar code reader and multi patient tracking. MDS also launched the cell phone application for nursing or physician staff, which shows real-time ECG and vital sign statistics for health care professionals away from the clinic or hospital.
August 11, 2010:
Please join MDS and 3F Medical at the Miami Beach Convention Center August 11-13 for FIME 2010. We will be in booth 901.
May 25, 2010:
MDS helps sign a new purchase order for a US based medical company with our strategic manufacturing partner in China, IMG Medical. This project allowed the US customer to lower their cost of goods considerably compaired to the existing manufacturing in Europe and Taiwan while providing a much higher quality, even compaired to the European components.
May 7, 2010:
MDS is proud to announce that we have just received FDA approval for the 3F Medical IRIS Patient Monitor ( www.irispatientmonitor.com ). We welcome any qualified distribution inquiries. Please contact us directly.
August 1, 2009:
Medical Device Systems has recently signed two separate contracts to be the exclusive U.S. representative for two very powerful contract manufacturing companies: 3F Medical Systems and IMG Medical.
Please see Contract Manufacturing attachments: Click Here
(click on images/logos for more information) FDA approved IRIS Patient Monitor
Please visit 3F Medical's website: http://www.3fmedical.cn/3f-medical-en.htm
Please visit I-Medical Company's website: http://www.i-tooling.com
________________________________________________________________________
Why China?
At a total $10.2B in 2008, China represents the 3rd largest medical device market in the world. With an average historical growth rate of 15% and an expected increase in growth taking the annual total to $17.5B in 2010 the opportunity is only getting bigger.
The anticipated increase is due to a policy of heavy new government investment in China’s healthcare infrastructure with the purpose of broadening access and coverage for the entire country. China’s best and most well funded hospitals are known as Level III and located largely in major metro areas. China’s Level I & II facilities are historically less well funded and represent the best opportunity for growth in the market.
The opportunity for US Medical Device Manufacturers is heightened by the perception in the Chinese marketplace that US products are the most advanced and of superior quality. Significant opportunities exist in the middle market for advanced and competitively priced products.
Source: 2009 MedTech Snapshot. International: Commitment to Growth and Reform in China.
